Linda Lebon

General Counsel at OSE IMMUNOTHERAPEUTICS

58 year

Health Technology

Consumer Services

Profile

Linda Lebon is currently the Chief Regulatory Officer at OSE Immunotherapeutics SA since 2021.
Prior to this, she worked as the Chief Regulatory Officer at Bone Therapeutics SA from 2018 to 2021.
Before that, she held the position of Vice President-Regulatory Affairs at argenx SE and Director-Regulatory Affairs at iTeos Therapeutics SA. Ms. Lebon holds an MBA from École des Hautes Études Commerciales de Paris and a graduate degree from Centre Hospitalier Universitaire de Liege.

Linda Lebon active positions

Companies	Position	Start
OSE IMMUNOTHERAPEUTICS	General Counsel	20/12/2021

All active positions of Linda Lebon

Former positions of Linda Lebon

Companies	Position	End
BIOSENIC SA	General Counsel	01/09/2021
ARGENX SE	General Counsel	-
iTeos Therapeutics SA iTeos Therapeutics SA Pharmaceuticals: MajorHealth Technology iTeos Therapeutics SA engages in the discovery of immunomodulators for cancer therapy. It operates as a biotechnology company which focuses on targeting metabolism of the tumor microenvironment through development of small-molecule immunomodulators for cancer treatment. The firm develops small molecules designed to target the tumor microenvironment by inhibiting cancer-induced immune suppression. Targeting such resistance mechanisms will enhance the clinical efficacy of both standards of care treatments as well as the newer immunomodulatory therapies based on the blockade of immune checkpoints. The company was founded in 2011 by Michel Detheux and Benoit Van den Eynde and is headquartered in Gosselies, Belgium.	General Counsel	-

See the detail of Linda Lebon's experience

Training of Linda Lebon

École des Hautes Études Commerciales de Paris	Masters Business Admin
Centre Hospitalier Universitaire de Liege	Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Linda Lebon's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	2
ARGENX SE	Health Technology
OSE IMMUNOTHERAPEUTICS	Health Technology

Private companies	2
Bone Therapeutics SA Bone Therapeutics SA Pharmaceuticals: MajorHealth Technology Bone Therapeutics SA is a cell therapy company, which engages in the regenerative therapy addressing for unmet medical needs in the field of bone diseases and orthopedics. Its products include Allob and JTA-004. The company was founded by Jacques Reymann on June 16, 2006 and is headquartered in Gosselies, Belgium.	Health Technology
iTeos Therapeutics SA iTeos Therapeutics SA Pharmaceuticals: MajorHealth Technology iTeos Therapeutics SA engages in the discovery of immunomodulators for cancer therapy. It operates as a biotechnology company which focuses on targeting metabolism of the tumor microenvironment through development of small-molecule immunomodulators for cancer treatment. The firm develops small molecules designed to target the tumor microenvironment by inhibiting cancer-induced immune suppression. Targeting such resistance mechanisms will enhance the clinical efficacy of both standards of care treatments as well as the newer immunomodulatory therapies based on the blockade of immune checkpoints. The company was founded in 2011 by Michel Detheux and Benoit Van den Eynde and is headquartered in Gosselies, Belgium.	Health Technology